Insider Transactions in Q1 2024 at Vertex Pharmaceuticals Inc (VRTX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2024
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Open market or private sale
|
Direct |
3,004
-5.15%
|
$1,276,700
$425.7 P/Share
|
|
Feb 26
2024
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Open market or private sale
|
Direct |
354
-0.63%
|
$150,450
$425.7 P/Share
|
|
Feb 26
2024
|
Edward Morrow Atkinson Iii EVP, Chief Technical Ops. Off. |
SELL
Open market or private sale
|
Direct |
883
-5.24%
|
$375,275
$425.7 P/Share
|
|
Feb 26
2024
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
5,034
-9.2%
|
$2,139,450
$425.7 P/Share
|
|
Feb 26
2024
|
Kristen Ambrose SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
883
-9.98%
|
$375,275
$425.7 P/Share
|
|
Feb 26
2024
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,239
-14.11%
|
$1,801,575
$425.7 P/Share
|
|
Feb 23
2024
|
Charles F Wagner Jr EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,309
-5.82%
|
$1,426,179
$431.79 P/Share
|
|
Feb 23
2024
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Payment of exercise price or tax liability
|
Direct |
2,469
-4.06%
|
$1,064,139
$431.79 P/Share
|
|
Feb 23
2024
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,309
-5.56%
|
$1,426,179
$431.79 P/Share
|
|
Feb 23
2024
|
Reshma Kewalramani CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,386
-6.43%
|
$4,045,366
$431.79 P/Share
|
|
Feb 23
2024
|
Carmen Bozic EVP and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,309
-8.22%
|
$1,426,179
$431.79 P/Share
|
|
Feb 23
2024
|
Edward Morrow Atkinson Iii EVP, Chief Technical Ops. Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,654
-8.94%
|
$712,874
$431.79 P/Share
|
|
Feb 23
2024
|
Stuart A Arbuckle EVP, COO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,714
-7.93%
|
$2,031,734
$431.79 P/Share
|
|
Feb 23
2024
|
Kristen Ambrose SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
828
-8.56%
|
$356,868
$431.79 P/Share
|
|
Feb 23
2024
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,970
-11.67%
|
$1,711,070
$431.79 P/Share
|
|
Feb 21
2024
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Open market or private sale
|
Direct |
360
-0.6%
|
$151,560
$421.77 P/Share
|
|
Feb 21
2024
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Open market or private sale
|
Direct |
3,191
-4.99%
|
$1,343,411
$421.77 P/Share
|
|
Feb 21
2024
|
Edward Morrow Atkinson Iii EVP, Chief Technical Ops. Off. |
SELL
Open market or private sale
|
Direct |
1,201
-6.09%
|
$505,621
$421.77 P/Share
|
|
Feb 21
2024
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,002
-8.11%
|
$1,263,842
$421.77 P/Share
|
|
Feb 21
2024
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
3,603
-5.72%
|
$1,516,863
$421.77 P/Share
|
|
Feb 20
2024
|
Charles F Wagner Jr EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,812
-4.71%
|
$1,181,040
$420.58 P/Share
|
|
Feb 20
2024
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Open market or private sale
|
Direct |
480
-0.8%
|
$201,600
$420.79 P/Share
|
|
Feb 20
2024
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,373
-5.3%
|
$1,416,660
$420.58 P/Share
|
|
Feb 20
2024
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Open market or private sale
|
Direct |
4,254
-6.23%
|
$1,786,680
$420.79 P/Share
|
|
Feb 20
2024
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Payment of exercise price or tax liability
|
Direct |
2,623
-3.7%
|
$1,101,660
$420.58 P/Share
|
|
Feb 20
2024
|
Jeffrey M Leiden Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
4,118
-23.01%
|
$1,729,560
$420.58 P/Share
|
|
Feb 20
2024
|
Reshma Kewalramani CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
7,019
-4.59%
|
$2,947,980
$420.58 P/Share
|
|
Feb 20
2024
|
Edward Morrow Atkinson Iii EVP, Chief Technical Ops. Off. |
SELL
Open market or private sale
|
Direct |
801
-3.91%
|
$336,420
$420.79 P/Share
|
|
Feb 20
2024
|
Edward Morrow Atkinson Iii EVP, Chief Technical Ops. Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,125
-5.2%
|
$472,500
$420.58 P/Share
|
|
Feb 20
2024
|
Carmen Bozic EVP and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,812
-6.53%
|
$1,181,040
$420.58 P/Share
|
|
Feb 20
2024
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
4,804
-7.08%
|
$2,017,680
$420.79 P/Share
|
|
Feb 20
2024
|
Stuart A Arbuckle EVP, COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,373
-4.74%
|
$1,416,660
$420.58 P/Share
|
|
Feb 20
2024
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,002
-9.75%
|
$1,680,840
$420.79 P/Share
|
|
Feb 20
2024
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,812
-6.41%
|
$1,181,040
$420.58 P/Share
|
|
Feb 16
2024
|
Charles F Wagner Jr EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,750
-5.91%
|
$1,590,000
$424.01 P/Share
|
|
Feb 16
2024
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,499
-6.6%
|
$1,907,576
$424.01 P/Share
|
|
Feb 16
2024
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Payment of exercise price or tax liability
|
Direct |
3,498
-4.7%
|
$1,483,152
$424.01 P/Share
|
|
Feb 16
2024
|
Reshma Kewalramani CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,359
-5.77%
|
$3,968,216
$424.01 P/Share
|
|
Feb 16
2024
|
Edward Morrow Atkinson Iii EVP, Chief Technical Ops. Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,501
-6.49%
|
$636,424
$424.01 P/Share
|
|
Feb 16
2024
|
Carmen Bozic EVP and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,750
-8.01%
|
$1,590,000
$424.01 P/Share
|
|
Feb 16
2024
|
Stuart A Arbuckle EVP, COO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,499
-5.94%
|
$1,907,576
$424.01 P/Share
|
|
Feb 16
2024
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,750
-7.88%
|
$1,590,000
$424.01 P/Share
|
|
Feb 15
2024
|
Jeffrey M Leiden Executive Chairman |
SELL
Open market or private sale
|
Direct |
4,655
-20.64%
|
$1,950,445
$419.16 P/Share
|
|
Feb 14
2024
|
Jeffrey M Leiden Executive Chairman |
SELL
Open market or private sale
|
Direct |
4,356
-16.19%
|
$1,825,164
$419.04 P/Share
|
|
Feb 13
2024
|
Jeffrey M Leiden Executive Chairman |
SELL
Open market or private sale
|
Direct |
737
-2.67%
|
$308,803
$419.13 P/Share
|
|
Feb 12
2024
|
Jeffrey M Leiden Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,656
-4.46%
|
$1,112,864
$419.81 P/Share
|
|
Feb 12
2024
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Open market or private sale
|
Direct |
314
-0.46%
|
$131,880
$420.24 P/Share
|
|
Feb 12
2024
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Open market or private sale
|
Direct |
3,222
-4.15%
|
$1,353,240
$420.24 P/Share
|
|
Feb 12
2024
|
Jonathan Biller EVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,738
-8.68%
|
$726,484
$418.77 P/Share
|
|
Feb 12
2024
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
4,295
-5.37%
|
$1,803,900
$420.24 P/Share
|